Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Glucose Transporters

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hepatitis E Is a Rare Finding in Liver Transplant Patients With Chronic Elevated Liver Enzymes and Biopsy-Proven Acute Rejection.

Transplantation proceedings·2020

Same author

Pretransplant coronary artery disease is a predictor for myocardial infarction and cardiac death after liver transplantation.

European journal of internal medicine·2017

Same author

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

Clinical pharmacology and therapeutics·2017

Same author

Nocebo effect of informed consent: circulatory collapse before elective caesarean section.

International journal of obstetric anesthesia·2016

Same author

Erratum to "Determination of the irradiation field at the research reactor TRIGA Mainz for BNCT" [J. Appl. Radiat. Isot. 67 (2009) S242-S246].

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2016

Same author

Erratum to: surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis.

Langenbeck's archives of surgery·2015

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Focal hepatic glycogenosis.

P Bannasch¹, U Jahn, H Hacker

¹UNIV HEIDELBERG, INST PATHOL, D-6900 HEIDELBERG, GERMANY. UNIV HANNOVER, DEPT SURG, HANNOVER, GERMANY. UNIV HEIDELBERG, DEPT SURG, D-6900 HEIDELBERG, GERMANY.

International Journal of Oncology

|May 3, 2011

Summary

This summary is machine-generated.

Foci of altered hepatocytes (FAH) with focal hepatic glycogenosis are found in human livers, particularly in patients with liver cancer and cirrhosis. These lesions show reduced glycogen breakdown enzymes, suggesting a role in hepatocyte neoplastic transformation.

More Related Videos

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination

Published on: February 8, 2022

Biochemical Titration of Glycogen In vitro

Biochemical Titration of Glycogen In vitro

Published on: November 24, 2013

Related Experiment Videos

Last Updated: Jun 2, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination

Published on: February 8, 2022

Biochemical Titration of Glycogen In vitro

Biochemical Titration of Glycogen In vitro

Published on: November 24, 2013

Area of Science:

Hepatology and Cancer Research
Biochemistry and Molecular Biology

Background:

Foci of altered hepatocytes (FAH), including those with focal hepatic glycogenosis, are recognized preneoplastic lesions in animal models of liver cancer.
Their presence and characteristics in human livers, especially in relation to liver diseases, require further investigation.

Purpose of the Study:

To investigate the occurrence and characteristics of FAH with focal hepatic glycogenosis in human livers.
To compare the enzyme histochemical profiles of FAH and hepatocellular carcinoma (HCC).

Main Methods:

Histological and histochemical analyses of 67 explanted and 2 resected human livers.
Enzyme histochemistry to assess the activity of various enzymes in FAH and HCC.

Main Results:

FAH were frequently detected in livers with HCC (14/14) and cirrhosis (21/42), but not in donor livers.
FAH showed significantly increased cell proliferation and consistent reductions in glycogen phosphorylase (98%) and glucose-6-phosphatase (95%) activity.
HCC exhibited distinct enzyme patterns, including increased mitochondrial glycerol-3-phosphate dehydrogenase activity, differing from FAH.

Conclusions:

Focal hepatic glycogenosis in humans is a putative preneoplastic lesion, mirroring findings in animal models.
This condition appears to be an early step in hepatocyte neoplastic transformation, involving metabolic shifts.